The MIR4739 gene is a member of the microRNA (miRNA) family, which plays a crucial role in the post-transcriptional regulation of gene expression. Here's a detailed overview of the gene, including the additional requested information:

### 1. Associated Genes:
While specific associations for MIR4739 with other genes can depend on ongoing research and context (like specific diseases or conditions), miRNAs typically regulate multiple target genes. Some gene targets that have been implicated in the broader miRNA network and are potentially associated with MIR4739 include:

- **CXCL12**: Involved in chemotaxis and cellular signaling.
- **VEGFA**: A key factor in angiogenesis that is often regulated by miRNAs.
- **TNF** (Tumor Necrosis Factor): Involved in systemic inflammation and regulation of immune cells.

To obtain the most current associations, it is advisable to refer to databases such as miRBase, TargetScan, or similar resources that maintain curated lists of miRNA targets.

### 2. Aging and Age-Related Diseases:
Research focusing on miRNAs in the context of aging has suggested that MIR4739 may play a role in the regulation of genes involved in aging or age-related diseases. While MIR4739 itself may not have extensive studies directly linking it to specific age-related phenotypes, microRNAs generally have been implicated in:

- **Neurodegenerative Diseases**: Alterations in miRNA expression have been associated with diseases like Alzheimer's and Parkinson's disease.
- **Metabolic Syndromes**: Changes in miRNA profiles, including those of the MIR family, have been observed in conditions like diabetes and obesity, which are often age-related.

Ongoing research is likely to shed more light on the specific roles of MIR4739 in these contexts as advances in genomic studies continue.

### 3. Drug Interactions:
As of the latest data up to October 2023, there are no specific approved drugs that have been definitively linked to direct interactions with MIR4739. However, several classes of drugs could potentially influence miRNA expression, including:

- **Antagomirs**: Synthetic oligonucleotides designed to inhibit specific miRNAs.
- **MiRNA mimics**: Compounds that enhance the function of specific miRNAs, potentially including those in the MIR family.

Since the therapeutic targeting of miRNAs is an area of intensive research, it would be best to consult current literature for any novel interactions.

### 4. Pathways and Biological Processes:
MIR4739 is likely involved in several biological pathways and processes associated with miRNAs, such as:

- **Post-Transcriptional Gene Regulation**: The primary function of miRNAs, including MIR4739, is to inhibit translation or destabilize target mRNAs.
- **Cell Cycle Regulation**: MiRNAs have been shown to play roles in cell proliferation and apoptosis.
- **Developmental Processes**: MiRNAs are often crucial during various stages of development and differentiation.
- **Inflammation and Immune Response**: MiRNAs modulate immune cell functions and inflammatory responses, influencing diseases like autoimmunity, cancer, and infections.

These pathways can significantly impact various physiological and pathological processes, suggesting that MIR4739 may have a broad regulatory role in normal cellular function and disease.

In summary, while insights into MIR4739 are ongoing and dynamic, its classification as a miRNA implicates it in complex regulatory networks essential for maintaining cellular homeostasis and responding to various conditions, including those associated with aging and pathology. For the latest and most specific information, including gene networks and drug interactions, it is advisable to consult updated bioinformatics platforms and peer-reviewed literature.